John D. Imig
Affiliations: | Medical College of Georgia, Augusta, GA, United States |
Area:
Molecular BiologyGoogle:
"John Imig"Children
Sign in to add trainee| Maninder M. Manhiani | grad student | 2008 | Medical College of Georgia |
| Alexis N. Simpkins | grad student | 2008 | Medical College of Georgia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Imig JD. (2023) Bioactive lipids in hypertension. Advances in Pharmacology (San Diego, Calif.). 97: 1-35 |
| Imig JD, Khan MAH, Stavniichuk A, et al. (2023) Salt-sensitive hypertension after reversal of unilateral ureteral obstruction. Biochemical Pharmacology. 210: 115438 |
| Imig JD. (2022) Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury. Advances in Pharmacology (San Diego, Calif.). 94: 27-55 |
| Baranowska I, Gawrys O, Walkowska A, et al. (2022) Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats. Frontiers in Pharmacology. 12: 798642 |
| Jankiewicz WK, Barnett SD, Stavniichuk A, et al. (2021) Dual sEH/COX-2 Inhibition Using PTUPB-A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity. Frontiers in Pharmacology. 12: 744776 |
| Walkowska A, Červenka L, Imig JD, et al. (2021) Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats. Frontiers in Physiology. 12: 622882 |
| Stavniichuk A, Savchuk O, Khan AH, et al. (2020) THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODEL. Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia. 80: 10-15 |
| Stavniichuk A, Savchuk O, Khan AH, et al. (2020) A SORAFENIB INDUCED MODEL OF GLOMERULAR KIDNEY DISEASE. Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia. 81: 25-31 |
| Stavniichuk A, Hye Khan MA, Yeboah MM, et al. (2020) Dual Soluble Epoxide Hydrolase Inhibitor/PPAR-γ Agonist Attenuates Renal Fibrosis. Prostaglandins & Other Lipid Mediators. 106472 |
| Imig JD, Jankiewicz WK, Khan AH. (2020) Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture. Hypertension (Dallas, Tex. : 1979). 76: 3-15 |